Back to search
Hypobetalipoproteinemias
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypobetalipoproteinemias trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypobetalipoproteinemias trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The aim of this study is to identify new targets in cholesterol metabolism thanks to a genetically-based strategy.
Hypobetalipoproteinemias (HBL) represent a heterogeneous group of disorders characterized by reduced plasma levels of plasmatic lipids (mainly triglycerides, to…